89
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Low dose melphalan in the treatment of myelofibrosis: A single centre experience

, &
Pages 1409-1412 | Accepted 23 Jan 2006, Published online: 01 Jul 2009

References

  • Manoharan A, Pitney W R. Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis. Scand J Haematol 1984; 33: 453–459
  • Lofvenberg E, Wahlin A, Roos G, Ost A. Reversal of myelofibrosis by hydroxyurea. Eur J Haematol 1990; 44: 33–38
  • Stott H, Fox W, Girling D J, Stephens R J, Galton D A. Acute leukemia after busulphan. BMJ 1977; 2: 1513–1517
  • Rupoli S, Da Lio L, Sisti S, Campanati G, Salvi A, Brianzoni M F, et al. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Ann Haematol 1994; 68: 205–212
  • Petti M C, Latagliata R, Spadea T, Spadea A, Montefusco E, Aloe Spiriti M A, et al. Melphalan treatment in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 2002; 116: 576–581
  • Dray S, Mokyr M B. Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy. Med Oncol Tumor Pharmacother 1989; 6: 77–85

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.